| Arsenic | Health-Based | N/A | 0.038 | Jun 30, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | May 31, 2025 | Active | N/A |
| Arsenic | Health-Based | N/A | 0.039 | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.039 | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.039 | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.039 | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 22, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 22, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 22, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 22, 2025 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.04 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.04 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.04 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.04 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.041 | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.041 | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.041 | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.041 | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Sep 23, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 23, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 23, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 23, 2024 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.037 | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.037 | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.037 | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.037 | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.038 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.038 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.0361 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.0361 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.0361 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.0361 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Health-Based | N/A | 95 | Dec 31, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 95 | Dec 31, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 95 | Dec 31, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 95 | Dec 31, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 95 | Dec 31, 2023 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.018 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 37 | Jun 30, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 37 | Jun 30, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 37 | Jun 30, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 37 | Jun 30, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 37 | Jun 30, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 178 | Mar 31, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 178 | Mar 31, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 178 | Mar 31, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 178 | Mar 31, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 178 | Mar 31, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 23 | Dec 31, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 23 | Dec 31, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 23 | Dec 31, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 23 | Dec 31, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 23 | Dec 31, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 24 | Sep 30, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 24 | Sep 30, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 24 | Sep 30, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 24 | Sep 30, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 24 | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 23 | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 23 | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 23 | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 23 | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 23 | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 22 | Dec 31, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 22 | Dec 31, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 22 | Dec 31, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 22 | Dec 31, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 22 | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 22 | Sep 30, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 22 | Sep 30, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 22 | Sep 30, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 22 | Sep 30, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 22 | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |